Indefinite Delivery Contract 36E79726D0012
- Not listed
- This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract, valued at up to $15,026,406.75, provides for the delivery of Bupropion SA 12HR tablets in various bottle sizes and quantities to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service over a base year period from May 16, 2021...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. to procure bupropion hydrochloride immediate release tablets. The contract has a one-year base period of performance beginning on November 14, 2019, plus four one-year option periods, for a potential total value of $4.285 million. Task orders will be placed against the contract through November 13, 2024 to facilitate delivery of the...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide an uninterrupted supply of Buspirone HCL tablets in various strengths and bottle configurations. The one-year base contract, with four one-year option periods, has a ceiling value of $18,126,658.75 and will leverage the VA and DoD Pharmaceutical Prime Vendor programs for efficient...
- Radha Pharmaceuticals Inc., a minority-owned manufacturer and distributor of generic pharmaceuticals, was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain division of the Department of Defense on October 6, 2022, with a ceiling value of $23.3 million and an ultimate completion date of October 5, 2027. The contract was awarded under full and open competition with no set-asides and originated from a pre-solicitation posted on March 11, 2021. This indefinite...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
- Radha Pharmaceuticals Inc., a minority-owned generic pharmaceutical manufacturer, was awarded a single-award indefinite delivery contract by the Veterans Affairs National Acquisition Center on January 1, 2024, with a ceiling value of approximately $23.5 million and a completion date of December 31, 2026. Under this firm-fixed pricing contract, Radha Pharmaceuticals supplies gabapentin tablets to support the Department of Veterans Affairs pharmaceutical supply chain. The contract was awarded...
- The federal contract IDV is a single-award Indefinite Delivery Contract awarded by the Department of Veterans Affairs (VA) National Acquisition Center to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $2,936,792.25 and a period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contract is for the procurement of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg strengths. The estimated...
- The Department of Veterans Affairs awarded a single-award indefinite delivery contract to DR Reddy's Laboratories, Inc. to supply an estimated 140,000 boxes annually of various strengths of Buprenorphine/Naloxone Film Sublingual. The contract has a one-year base period of performance beginning February 4, 2020 with four one-year option periods and a potential value of $42,763,747.32. The original solicitation sought to establish a prime vendor contract to supply Buprenorphine/Naloxone Film...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the supply of Clopidogrel Bisulfate tablets. The $15,979,579.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of April 14, 2026. The contract aims to provide an uninterrupted supply of Clopidogrel Bisulfate tablets in various bottle...
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The single-award, $10,819,189.25 ceiling value contract is for the supply of various generic pharmaceutical products, including tablets and capsules containing gabapentin, atorvastatin calcium, clopidogrel bisulfate, fluoxetine hydrochloride, bupropion HCL ER, naproxen, hydralazine, and celecoxib. The...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Radha Pharmaceuticals Inc. (UEI: C1S5SQ88KY67) for the supply of Bupropion Hydrochloride 12-hour Sustained Action Tablets on May 16, 2026. The contract carries a ceiling value of $8.28 million and utilizes firm-fixed pricing with a base year ordering period from May 16, 2026 through May 15, 2027, followed by four one-year option periods extending through May 15, 2031. This unrestricted competition, conducted without set-aside designations, was issued in commercial item format under Federal Acquisition Regulation Part 12. The procurement serves multiple federal agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through established distribution channels encompassing the VA's Consolidated Mail Order Pharmacies and State Veterans Homes. The solicitation specified strict technical and packaging requirements for all offerors, mandating safety caps with deshelling capabilities, 120-cubic-centimeter minimum bottle volume, cylindrical bottle bodies with precise dimensions, and unique National Drug Code numbers for each supplier's labeled product. Estimated annual requirements encompassed five tablet configurations across both 60-count safety-cap bottles and 500-count non-safety bottles, with total annual usage ranging from 20,289 to 158,669 bottles depending on dosage strength and packaging type. As a minority-owned generic pharmaceutical manufacturer, Radha Pharmaceuticals Inc. holds multiple indefinite delivery contracts with the VA and Defense Logistics Agency Troop Support Medical for high-volume pharmaceutical supplies, positioning the company to reliably fulfill the uninterrupted supply commitments and estimated annual unit requirements exceeding 200,000 units across its federal government customer base.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/10/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Bupropion HCL 12HR SA Tablets Effective 05/16/2026 - 05/15/2027 | 36E79725R0065 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 12/10/25, 9:53 AM | |
6505--Bupropion Tablets 12hr SA Tablets | 36E79725R0065 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 10/20/25, 11:02 AM | |
6505--Bupropion Tablets 12hr SA Tablets | 36E79725R0065 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 11/4/25, 9:37 AM |